Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urea Cycle Disorders.

Soledad Kleppe1, Asad Mian, Brendan Lee

  • 1Department of Molecular and Human Genetics and Howard Hughes Medical Institute, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA. blee@bcm.tmc.edu

Current Treatment Options in Neurology
|June 7, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Self-perceived burden and mental health outcomes in adults with osteogenesis imperfecta.

Journal of health psychology·2026
Same author

Sociodemographic and clinical predictors of resilience in individuals with osteogenesis imperfecta.

Disability and health journal·2026
Same author

Infertility as a possible diagnostic feature of Carney complex.

JCEM case reports·2026
Same author

Apolipoprotein L1 (APOL1) and Nephropathy.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same author

Comparative analysis of clearing methods for 3D imaging of the vasculature in mineralized mouse tissues.

iScience·2026
Same author

Mechanical characterization of <i>Col1a1</i> <sup>+/-</sup> osteogenesis imperfecta bone revealed altered mechanical stiffness heterogeneity across scales.

Cell biomaterials·2026
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Urea cycle disorders are metabolic conditions causing brain damage from high ammonia levels. Treatments aim to manage nitrogen levels, with new cell and gene therapies emerging.

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Background:

  • Urea cycle disorders (UCDs) are inherited metabolic diseases.
  • They involve gene-nutrient interactions leading to hyperammonemia.
  • Hyperammonemia causes significant acute and chronic neurotoxicity.

Purpose of the Study:

  • To review current and evolving treatment paradigms for UCDs.
  • To highlight research on the pathophysiology of ammonia toxicity.
  • To discuss strategies for preventing neural injury in UCD patients.

Main Methods:

  • Literature review of existing treatments.
  • Analysis of emerging cell and gene therapies.
  • Summary of current research directions in UCD pathophysiology.

Related Experiment Videos

Main Results:

  • Current treatments focus on managing nitrogen flux via diet and medication.
  • Cell and gene therapies represent promising future treatment avenues.
  • Understanding ammonia's neurotoxic mechanisms is crucial for prevention.

Conclusions:

  • UCDs require comprehensive management strategies.
  • Novel therapies are under development to address UCDs.
  • Further research is essential for preventing neurological damage in UCDs.